|
|
DSpace at RU >
Browsing by Author Zwaan, C.M.
Showing results 1 to 8 of 8
| Full Text | Issue Date | Title | Author(s) | | 2012 | High GATA2 expression is a poor prognostic marker in pediatric acute myeloid leukemia. | Luesink, M.; Hollink, I.H.; Velden, V.H. van der; Knops, R.H.; Boezeman, J.B.M., et al |
| 2012 | Assessing children's competence to consent in research by a standardized tool: a validity study | Hein, I.M.; Troost, P.W.; Lindeboom, R.; de Vries, M.C. de; Zwaan, C.M., et al |
| 2011 | TET2 mutations in childhood leukemia | Langemeijer, S.M.C.; Jansen, J.H.; Hooijer, J.; Hoogen, P.C.M. van; Stevens-Linders, E.H.P., et al |
| 2010 | EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia. | Balgobind, B.V.; Lugthart, S.; Hollink, I.H.; Arentsen-Peters, S.T.; Wering, E.R. van, et al |
| 2010 | Low frequency of MLL-partial tandem duplications in paediatric acute myeloid leukaemia using MLPA as a novel DNA screenings technique. | Balgobind, B.V.; Hollink, I.H.; Reinhardt, D.; Wering, E.R. van; Graaf, S.S.N. de, et al |
| 2009 | Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia. | Hollink, I.H.; Heuvel-Eibrink, M.M. van den; Zimmermann, M.; Balgobind, B.V.; Arentsen-Peters, S.T., et al |
| 2009 | Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML. | Hollink, I.H.; Zwaan, C.M.; Zimmermann, M.; Arentsen-Peters, T.C.; Pieters, R., et al |
| 2005 | Treatment strategy and results in children treated on three Dutch Childhood Oncology Group acute myeloid leukemia trials. | Kardos, G.; Zwaan, C.M.; Kaspers, G.J.L.; Graaf, S.S.N. de; Bont, E.S. de, et al |
Showing results 1 to 8 of 8
|